Skip to main content
Article thumbnail
Location of Repository

Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cells

By Omar Nyabi, Michael Naessens, Katharina Haigh, Agnieszka Gembarska, Steven Goossens, Marion Maetens, Sarah De Clercq, Benjamin Drogat, Lieven Haenebalcke, Sonia Bartunkova, Ilse De Vos, Bram De Craene, Mansour Karimi, Geert Berx, Andras Nagy, Pierre Hilson, Jean-Christophe Marine and Jody J. Haigh


The ability to rapidly and efficiently generate reliable Cre/loxP conditional transgenic mice would greatly complement global high-throughput gene targeting initiatives aimed at identifying gene function in the mouse. We report here the generation of Cre/loxP conditional ROSA26-targeted ES cells within 3–4 weeks by using Gateway® cloning to build the target vectors. The cDNA of the gene of interest can be expressed either directly by the ROSA26 promoter providing a moderate level of expression or by a CAGG promoter placed in the ROSA26 locus providing higher transgene expression. Utilization of F1 hybrid ES cells with exceptional developmental potential allows the production of germ line transmitting, fully or highly ES cell-derived mice by aggregation of cells with diploid embryos. The presented streamlined procedures accelerate the examination of phenotypical consequences of transgene expression. It also provides a unique tool for comparing the biological activity of polymorphic or splice variants of a gene, or products of different genes functioning in the same or parallel pathways in an overlapping manner

Topics: Methods Online
Publisher: Oxford University Press
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2006). A DNA insulator prevents repression of a targeted X-linked transgene but not its random or imprinted X inactivation.
  2. (1978). A technique for detection and relative quantitative analysis of glucosephosphate isomerase isozymes from nanogram tissue samples.
  3. (1993). Cis effect of lacZ sequences in transgenic mice.
  4. (2000). Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice.
  5. (2007). Conditional brain-specific knockdown of MAPK using Cre/loxP regulated RNA interference.
  6. (2001). Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus.
  7. (2007). Developmental and adult phenotyping directly from mutant embryonic stem cells.
  8. (1997). Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells.
  9. (1999). Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.
  10. (2000). DNA cloning using in vitro site-specific recombination.
  11. (1982). Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes.
  12. (1994). E-cadherin null mutant embryos fail to form a trophectoderm epithelium.
  13. (2002). Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain.
  14. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector.
  15. (1981). Establishment in culture of pluripotential cells from mouse embryos.
  16. (2006). Expression of transgenes targeted to the Gt(ROSA)26Sor locus is orientation dependent.
  17. (2007). Gateway recombinatorial cloning: a biological operating system.
  18. (1999). Generalized lacZ expression with the ROSA26 Cre reporter strain.
  19. (1980). Genetic transformation of mouse embryos by microinjection of purified DNA.
  20. (1998). Improved properties of FLP recombinase evolved by cycling mutagenesis.
  21. (1994). Insertional mutagenesis in transgenic mice.
  22. (2006). Insulators: exploiting transcriptional and epigenetic mechanisms.
  23. (1981). Introduction of a rabbit beta-globin gene into the mouse germ line.
  24. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.
  25. (2004). ORFeome projects: gateway between genomics and omics.
  26. (1990). Position effects on eukaryotic gene expression.
  27. (2007). Recombinational cloning with plant gateway vectors.
  28. (2007). Reversible gene knockdown in
  29. (2001). Sequence and chromosomal context effects on variegated expression of keratin 5/lacZ constructs in stratified epithelia of transgenic mice.
  30. (2005). Single copy shRNA configuration for ubiquitous gene knockdown in mice.
  31. (2001). Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase.
  32. (2003). Sitespecific cassette exchange and germline transmission with mouse ES cells expressing phiC31 integrase.
  33. (2007). Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
  34. (1981). Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs.
  35. (1993). Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
  36. (2000). Targeting: A Practical Approach.
  37. (2007). The alliance for cellular signaling plasmid collection: a flexible resource for protein localization studies and signaling pathway analysis.
  38. (1981). The human beta-globin gene and a functional viral thymidine kinase gene in developing mice.
  39. (2003). The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors.
  40. (2000). The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression.
  41. (2000). The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells.
  42. (2005). Unraveling signalling cascades for the Snail family of transcription factors.
  43. (1999). Z/AP, a double reporter for cre-mediated recombination.
  44. (2000). Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.